State Street’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161M | Buy |
4,942,235
+534,552
| +12% | +$17.4M | 0.01% | 1042 |
|
|
2025
Q1 | $166M | Sell |
4,407,683
-131,723
| -3% | -$4.97M | 0.01% | 997 |
|
|
2024
Q4 | $372M | Buy |
4,539,406
+1,133,663
| +33% | +$92.8M | 0.01% | 627 |
|
|
2024
Q3 | $389M | Buy |
3,405,743
+38,596
| +1% | +$4.41M | 0.02% | 600 |
|
|
2024
Q2 | $254M | Buy |
3,367,147
+30,055
| +0.9% | +$2.27M | 0.01% | 738 |
|
|
2024
Q1 | $228M | Sell |
3,337,092
-52,436
| -2% | -$3.58M | 0.01% | 810 |
|
|
2023
Q4 | $213M | Buy |
3,389,528
+244,269
| +8% | +$15.3M | 0.01% | 807 |
|
|
2023
Q3 | $160M | Sell |
3,145,259
-18,053
| -0.6% | -$920K | 0.01% | 886 |
|
|
2023
Q2 | $158M | Buy |
3,163,312
+87,296
| +3% | +$4.36M | 0.01% | 929 |
|
|
2023
Q1 | $115M | Sell |
3,076,016
-91,965
| -3% | -$3.45M | 0.01% | 1087 |
|
|
2022
Q4 | $152M | Buy |
3,167,981
+1,174,945
| +59% | +$56.3M | 0.01% | 907 |
|
|
2022
Q3 | $47.8M | Buy |
1,993,036
+137,392
| +7% | +$3.3M | ﹤0.01% | 1620 |
|
|
2022
Q2 | $40.4M | Buy |
1,855,644
+471,476
| +34% | +$10.3M | ﹤0.01% | 1791 |
|
|
2022
Q1 | $33.4M | Buy |
1,384,168
+209,237
| +18% | +$5.05M | ﹤0.01% | 2025 |
|
|
2021
Q4 | $28M | Buy |
1,174,931
+38,677
| +3% | +$920K | ﹤0.01% | 2221 |
|
|
2021
Q3 | $28.8M | Sell |
1,136,254
-367,009
| -24% | -$9.31M | ﹤0.01% | 2211 |
|
|
2021
Q2 | $33.8M | Sell |
1,503,263
-268,813
| -15% | -$6.05M | ﹤0.01% | 2131 |
|
|
2021
Q1 | $35M | Buy |
1,772,076
+850,246
| +92% | +$16.8M | ﹤0.01% | 1999 |
|
|
2020
Q4 | $24.5M | Buy |
921,830
+647,789
| +236% | +$17.2M | ﹤0.01% | 2119 |
|
|
2020
Q3 | $13.5M | Buy |
+274,041
| New | +$13.5M | ﹤0.01% | 2263 |
|